Abstract
Purpose This study aims to assess health-related quality of life (HRQOL) in type 2 diabetic patients across four domains—physical, psychological, social, and environmental—and explore the possible determinants of these domains.
Methods Using a cross-sectional study design, 397 type 2 diabetic patients in Alain city were interviewed using validated questionnaires in three different care settings: primary, secondary and private health care facilities. The WHO Quality of Life instrument, generalized anxiety disorder score, and Patient Health Questionnaire (PHQ9) were employed.
Results The participants comprised 270 females (68%) and 127 males (32%), with 68.9% in the 41–65 years age group; 49.6% were married. The most common comorbidities were dyslipidemia (69.3%), hypertension (61%), and osteoarthritis (24.7%). On a scale of 0 to 100, the highest QOL mean score was reported in the social relationship domain (78.3), followed by the environmental (77.7), psychological health (74.2), and physical health (70.7) domains.
The risk of depression was a strong determinant of poor physical health. Social factors have great impact on a patient’s health and well-being. We noticed no difference in HRQOL outcome between primary, secondary, and private health care facilities.
Conclusion The social and mental health domains were the most influential in HRQOL among the participants. This finding supports targeting QOL assessments of patients with type 2 diabetes at the regular chronic diseases clinics and in the planning of population health management programs to ensure the best outcomes.
Plain English Summary Diabetes mellitus is considered a major cause of morbidity and mortality worldwide. In our study we are aiming to explore difference in quality of life and quality of care in patients who access different health care facilities, primary health care clinics versus patients following in secondary care center and private center in Alain. By doing so, we will expand the knowledge regarding health related quality of life of people with diabetes in the UAE and opens the door for future international collaborative research in Diabetes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
not funded
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Research approved by AHS SEHA Ethical committee
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data referred to in the manuscript of this study can be made available from the corresponding authors upon request.
Abbreviation
- (HRQOL)
- Health-related quality of life
- (PHQ9),)
- Patient Health Questionnaire
- (specifically, GAD7)
- Generalized anxiety disorder
- (WHO)
- The World Health Organization
- (AHS)
- Ambulatory Healthcare Services
- (IDF)
- International Diabetes Federation.
